Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies

17 Mar 2014

Abstract excerpt

Blurring the boundary between innate and adaptive immune system, natural killer (NK) cells are widely recognized as potent anti-leukemia mediators. Alloreactive donor NK cells have been shown to improve the outcome of allogeneic stem-cell transplantation for leukemia. In addition, in vivo transfer of NK cells may soon reveal an important therapeutic tool for leukemia, if tolerance to NK-mediated anti-leukemia...

Source

Identifiers

PMID: 24672522
DOI: 10.3389/fimmu.2014.00095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic StrategiesPMID 24672522Read ↗

High-Risk Leukemia: Past, Present, and Future Role of NK CellsSemantic proximity Read ↗

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity Read ↗

Adoptive NK cell therapy in AML: progress and challengesSemantic proximity Read ↗

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.Semantic proximity Read ↗

The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia.Semantic proximity Read ↗

Natural killer cell‐based immunotherapy in cancer: current insights and future prospectsSemantic proximity Read ↗

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK cells with Enhanced Antitumor Activity.Semantic proximity Read ↗

Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.Semantic proximity Read ↗

Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cellsSemantic proximity Read ↗

Natural Killer Cell Alloreactivity for Leukemia TherapySemantic proximity Read ↗

Human NK receptors: From the molecules to the therapy of high risk leukemiasSemantic proximity Read ↗

Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.